Mikael Von Euler
Board member
Targovax
Norway
Biography
Dr. Mikael von EulerMD, PhD, FFPM Most recently with Roche 2007-2010, Mikael held global clinical responsibility for the HER family of compounds including Herceptin, Pertuzumab and Tarceva, and acted as a Cluster Head for the HER2 Franchise. Prior to Roche, Mikael was Vice President, Oncology MDC, Europe, at GlaxoSmithKline and worked across several key clinical development roles at AstraZeneca.
Research Interest
management
